Cantharis comp. Soluzione iniettabile (s. c.) Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

cantharis comp. soluzione iniettabile (s. c.)

wala schweiz ag - achillea millefolium ferm 33d (hab) d3, cantharis ex animale toto sicca gl d6 (sv), equisetum arvense ex herba sicc. ferm 35b d3 (hab 35b), vesica urinaria bovis gl d7 (hab 41c), natrium - soluzione iniettabile (s. c.) - achillea millefolium ferm 33d (hab) d3 100.0 mg, cantharis ex animale toto sicca gl d6 (sv) 100.0 mg, equisetum arvense ex herba sicc. ferm 35b d3 (hab 35b) 100.0 mg, vesica urinaria bovis gl d7 (hab 41c) 100.0 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, ad solutionem pro 1 ml corresp. natrium 3.51 mg. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - antroposofici

Solum uliginosum comp. Soluzione iniettabile (s. c.) Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

solum uliginosum comp. soluzione iniettabile (s. c.)

wala schweiz ag - aesculus hippocastanum e semine rec. ferm 34c d11 (hab 34c), equisetum arvense ex herba sicc. ferm 35b d11 (hab 35b), solum uliginosum d11 (hab 5b) - soluzione iniettabile (s. c.) - aesculus hippocastanum e semine rec. ferm 34c d11 (hab 34c) 100 mg, equisetum arvense ex herba sicc. ferm 35b d11 (hab 35b) 100 mg, solum uliginosum d11 (hab 5b) 100 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, pro vitro 1 ml corresp. natrium 3.51 mg. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - antroposofici

Disci/Viscum comp. cum Stanno Creme Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

disci/viscum comp. cum stanno creme

wala schweiz ag - disci intervertebrales bovis gl (hab) d3, equisetum arvense ex herba sicc. ferm 35b d1 (hab 35b), formica rufa et formica polyctena ex animale toto gl d3 (hab 41c), phyllostachys viridiglaucescens e nodo rec. ferm 35c d1 (hab 35c), stannum metallicum (hab) d4, viscum album (mali) e planta tota recens ferm 34i d1 (hab 34i) - creme - disci intervertebrales bovis gl (hab) d3 10 mg, equisetum arvense ex herba sicc. ferm 35b d1 (hab 35b) 10 mg, formica rufa et formica polyctena ex animale toto gl d3 (hab 41c) 10 mg, phyllostachys viridiglaucescens e nodo rec. ferm 35c d1 (hab 35c) 10 mg, stannum metallicum (hab) d4 10 mg, viscum album (mali) e planta tota recens ferm 34i d1 (hab 34i) 10 mg, adeps lanae 270 mg, vaselinum album, arachidis oleum 405 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, ad unguentum pro 1 g. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - antroposofici

Prick-Testlösung Wiesenlieschgras (Pollen) Pricktestlösung Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

prick-testlösung wiesenlieschgras (pollen) pricktestlösung

bencard ag - pollinis allergeni extractum (phleum pratense) - pricktestlösung - pollinis allergeni extractum (phleum pratense) 10000 u., natrii chloridum, glycerolum, phenolum, aqua ad iniectabile ad solutionem pro 1 ml. - allergia-diagnosi - allergeni: prodotto diagnostico

Staloral Pollen Wiesenlieschgras Kombipackung Lösung zur sublingualen Anwendung Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

staloral pollen wiesenlieschgras kombipackung lösung zur sublingualen anwendung

stallergenes ag - pollinis allergeni extractum (phleum pratense) - lösung zur sublingualen anwendung - a): pollinis allergeni extractum (phleum pratense) 0.1 u., excipiens ad solutionem pro 1 ml. b): pollinis allergeni extractum (phleum pratense) 1.0 u., excipiens ad solutionem pro 1 ml. c): pollinis allergeni extractum (phleum pratense) 10 u., excipiens ad solutionem pro 1 ml. d): pollinis allergeni extractum (phleum pratense) 100 u., excipiens ad solutionem pro 1 ml. - hyposensibilisierung - allergene

Staloral Pollen Wiesenlieschgras 100IR Lösung zur sublingualen Anwendung Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

staloral pollen wiesenlieschgras 100ir lösung zur sublingualen anwendung

stallergenes ag - pollinis allergeni extractum (phleum pratense) - lösung zur sublingualen anwendung - pollinis allergeni extractum (phleum pratense) 100 u., excipiens ad solutionem pro 1 ml. - hyposensibilisierung - allergene

Alustal Wiesenlieschgras Kombipackung Injektionssuspension Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

alustal wiesenlieschgras kombipackung injektionssuspension

stallergenes ag - pollinis allergeni extractum (phleum pratense) - injektionssuspension - a): pollinis allergeni extractum (phleum pratense) 0.01 u., natrii chloridum, aluminii hydroxidum hydricum ad adsorptionem, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. b): pollinis allergeni extractum (phleum pratense) 0.1 u., natrii chloridum, aluminii hydroxidum hydricum ad adsorptionem, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. c): pollinis allergeni extractum (phleum pratense) 1.0 u., natrii chloridum, aluminii hydroxidum hydricum ad adsorptionem, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. d): pollinis allergeni extractum (phleum pratense) 10 u., natrii chloridum, aluminii hydroxidum hydricum ad adsorptionem, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. - hyposensibilisierung - allergene

Alustal Wiesenlieschgras 10IR Injektionssuspension Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

alustal wiesenlieschgras 10ir injektionssuspension

stallergenes ag - pollinis allergeni extractum (phleum pratense) - injektionssuspension - pollinis allergeni extractum (phleum pratense) 10 u., natrii chloridum, aluminii hydroxidum hydricum ad adsorptionem, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. - hyposensibilisierung - allergene

Phostal Wiesenlieschgras Kombipackung Injektionssuspension Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

phostal wiesenlieschgras kombipackung injektionssuspension

stallergenes ag - pollinis allergeni extractum (phleum pratense) - injektionssuspension - a): pollinis allergeni extractum (phleum pratense) 0.01 u., natrii chloridum, glycerolum, tricalcii phosphas, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. b): pollinis allergeni extractum (phleum pratense) 0.1 u., natrii chloridum, glycerolum, tricalcii phosphas, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. c): pollinis allergeni extractum (phleum pratense) 1.0 u., natrii chloridum, glycerolum, tricalcii phosphas, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. d): pollinis allergeni extractum (phleum pratense) 10 u., natrii chloridum, glycerolum, tricalcii phosphas, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. - hyposensibilisierung - allergene

Phostal Wiesenlieschgras 10IR Injektionssuspension Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

phostal wiesenlieschgras 10ir injektionssuspension

stallergenes ag - pollinis allergeni extractum (phleum pratense) - injektionssuspension - pollinis allergeni extractum (phleum pratense) 10 u., natrii chloridum, glycerolum, tricalcii phosphas, mannitolum, conserv.: phenolum 4.0 mg, aqua ad iniectabilia q.s. ad suspensionem pro 1 ml. - hyposensibilisierung - allergene